Skip to main content

Fairmount Funds Management LLC

Position in CBIO — Crescent Biopharma, Inc.

CIK 1802528 WEST CONSHOHOCKEN, PA

Position in CBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$49,461,588
-$1,016,710 QoQ
Shares Held
2,747,866
0.0% QoQ
Ownership
7.40%
of shares outstanding
% of Portfolio
3.27%
of 13F equity value
Holder Rank
#3
of 79 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Fairmount Funds Management LLC holds $1,512,967,792 across 12 Biotechnology names. CBIO ranks #9 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CBIO

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-07-16 $99,626,047 6,593,385
2026-06-30 $49,461,588 2,747,866
2026-03-31 $50,478,298 2,747,866
2025-12-31 $32,589,690 2,747,866
2025-12-04 $73,308,831 5,643,482
2025-09-30 $16,501,726 1,387,866
2025-06-30 $22,400,157 1,387,866
2025-06-13 $49,987,520 3,124,220